story of the week
Effect of SGLT2 Inhibitors on Risk of Hyperkalemia in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 diabetes: A Meta-analysis of Individual Participant Data from Randomized Controlled Trials
Circulation 2022 Apr 08;[EPub Ahead of Print], BL Neuen, M Oshima, R Agarwal, C Arnott, DZ Cherney, R Edwards, AM Langkilde, KW Mahaffey, DK McGuire, B Neal, V Perkovic, A Pong, MS Sabatine, I Raz, T Toyama, C Wanner, DC Wheeler, SD Wiviott, B Zinman, HJL HeerspinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.